Skip to main content
Atrás
Watch Compare

United Health Products, Inc.

Calidad de datos: 100%
UEEC
OTC Manufacturing Measuring & Analyzing Instruments
$0.05
▲ $0.00 (2.08%)
Cap. Mercado: 12.68 M
Precio
$0.05
Cap. Mercado
12.68 M
Rango del Día
$0.05 — $0.05
Rango de 52 Semanas
$0.04 — $0.28
Volumen
36,020
Apertura $0.05
Promedio 50D / 200D
$0.06
14.93% below
Promedio 50D / 200D
$0.07
29.90% below

Quick Summary

Puntos Clave

Negative free cash flow of -815,253.0

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio0.02
Interest Coverage-32.29

Valoración

PE (TTM)
-3.31
Below sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -3.3 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -3.83 M
ROE N/A ROA -4356.54%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -815,253.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.02
Interest Coverage -32.29 Asset Turnover 0.00
Working Capital -1.96 M Tangible Book Value -3.36 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.31 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -6.43%
Market Cap 12.68 M Enterprise Value 13.60 M
Per Share
EPS (Diluted TTM) -0.02 Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 21.28%
SBC-Adj. FCF -815,253 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0.0 0.0 37,500.0 59.0 643.0
Net Income -2.00 M -2.62 M -1.69 M -30.55 M -15.71 M
EPS (Diluted) -0.01 — — — —
Gross Profit — 0.0 18,856.0 34.0 448.0
Operating Income -2.01 M -2.43 M -2.80 M -29.80 M -14.85 M
EBITDA — — — — —
R&D Expenses 355,936.0 598,810.0 624,564.0 237,458.0 245,218.0
SG&A Expenses 1.65 M 1.83 M 2.20 M 29.56 M 14.60 M
D&A 4,050.0 4,050.0 — — —
Interest Expense 32,322.0 40,512.0 17,022.0 226,139.0 210,025.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 269,979.0 284,643.0 350,528.0 26,799.0 217,100.0
Total Liabilities 2.71 M 2.00 M 2.42 M 1.17 M 1.17 M
Shareholders' Equity -2.44 M -1.71 M -2.06 M -1.14 M -953,262.0
Total Debt — — — — —
Cash & Equivalents — — 13,377.0 21,799.0 46,076.0
Current Assets 191,683.0 151,822.0 71,039.0 26,799.0 115,750.0
Current Liabilities 1.64 M 1.95 M 2.42 M 1.17 M 1.17 M